Value |
Description |
German Interpretation |
Comment |
Chapter |
54 |
adenovirus, type 4 |
|
|
4.23.2 |
55 |
adenovirus, type 7 |
|
|
4.23.2 |
82 |
adenovirus, NOS1 |
|
|
4.23.2 |
24 |
anthrax |
|
|
4.23.2 |
19 |
BCG |
|
|
4.23.2 |
27 |
botulinum antitoxin |
|
|
4.23.2 |
26 |
cholera |
|
|
4.23.2 |
29 |
CMVIG |
|
|
4.23.2 |
56 |
dengue fever |
|
|
4.23.2 |
12 |
diphtheria antitoxin |
|
|
4.23.2 |
28 |
DT (pediatric) |
|
|
4.23.2 |
20 |
DTaP |
|
|
4.23.2 |
106 |
DTaP, 5 pertussis antigens |
|
|
4.23.2 |
107 |
DTaP, NOS |
|
|
4.23.2 |
50 |
DTaP-Hib |
|
|
4.23.2 |
01 |
DTP |
|
|
4.23.2 |
22 |
DTP-Hib |
|
|
4.23.2 |
102 |
DTP-Hib-Hep B |
|
|
4.23.2 |
57 |
hantavirus |
|
|
4.23.2 |
52 |
Hep A, adult |
|
|
4.23.2 |
83 |
Hep A, ped/adol, 2 dose |
|
|
4.23.2 |
84 |
Hep A, ped/adol, 3 dose |
|
|
4.23.2 |
31 |
Hep A, pediatric, NOS |
|
|
4.23.2 |
85 |
Hep A, NOS |
|
|
4.23.2 |
104 |
Hep A-Hep B |
|
|
4.23.2 |
30 |
HBIG |
|
|
4.23.2 |
08 |
Hep B, adolescent or pediatric |
|
|
4.23.2 |
42 |
Hep B, adolescent/high risk infant2 |
|
|
4.23.2 |
43 |
Hep B, adult4 |
|
|
4.23.2 |
44 |
Hep B, dialysis |
|
|
4.23.2 |
45 |
Hep B, NOS |
|
|
4.23.2 |
58 |
Hep C |
|
|
4.23.2 |
59 |
Hep E |
|
|
4.23.2 |
60 |
herpes simplex 2 |
|
|
4.23.2 |
46 |
Hib (PRP-D) |
|
|
4.23.2 |
47 |
Hib (HbOC) |
|
|
4.23.2 |
48 |
Hib (PRP-T) |
|
|
4.23.2 |
49 |
Hib (PRP-OMP) |
|
|
4.23.2 |
17 |
Hib, NOS |
|
|
4.23.2 |
51 |
Hib-Hep B |
|
|
4.23.2 |
61 |
HIV |
|
|
4.23.2 |
62 |
HPV |
|
|
4.23.2 |
86 |
IG |
|
|
4.23.2 |
87 |
IGIV |
|
|
4.23.2 |
14 |
IG, NOS |
|
|
4.23.2 |
15 |
influenza, split (incl. purified surface antigen) |
|
|
4.23.2 |
16 |
influenza, whole |
|
|
4.23.2 |
88 |
influenza, NOS |
|
|
4.23.2 |
10 |
IPV |
|
|
4.23.2 |
02 |
OPV |
|
|
4.23.2 |
89 |
polio, NOS |
|
|
4.23.2 |
39 |
Japanese encephalitis |
|
|
4.23.2 |
63 |
Junin virus |
|
|
4.23.2 |
64 |
leishmaniasis |
|
|
4.23.2 |
65 |
leprosy |
|
|
4.23.2 |
66 |
Lyme disease |
|
|
4.23.2 |
03 |
MMR |
|
|
4.23.2 |
04 |
M/R |
|
|
4.23.2 |
94 |
MMRV |
|
|
4.23.2 |
67 |
malaria |
|
|
4.23.2 |
05 |
measles |
|
|
4.23.2 |
68 |
melanoma |
|
|
4.23.2 |
32 |
meningococcal |
|
|
4.23.2 |
103 |
meningococcal C conjugate |
|
|
4.23.2 |
108 |
meningococcal, NOS |
|
|
4.23.2 |
07 |
mumps |
|
|
4.23.2 |
69 |
parainfluenza-3 |
|
|
4.23.2 |
11 |
pertussis |
|
|
4.23.2 |
23 |
plague |
|
|
4.23.2 |
33 |
pneumococcal |
|
|
4.23.2 |
100 |
pneumococcal conjugate |
|
|
4.23.2 |
109 |
pneumococcal, NOS |
|
|
4.23.2 |
70 |
Q fever |
|
|
4.23.2 |
18 |
rabies, intramuscular injection |
|
|
4.23.2 |
40 |
rabies, intradermal injection |
|
|
4.23.2 |
90 |
rabies, NOS |
|
|
4.23.2 |
72 |
rheumatic fever |
|
|
4.23.2 |
73 |
Rift Valley fever |
|
|
4.23.2 |
34 |
RIG |
|
|
4.23.2 |
74 |
rotavirus |
|
|
4.23.2 |
71 |
RSV-IGIV |
|
|
4.23.2 |
93 |
RSV-MAb |
|
|
4.23.2 |
06 |
rubella |
|
|
4.23.2 |
38 |
rubella/mumps |
|
|
4.23.2 |
75 |
smallpox |
|
|
4.23.2 |
105 |
smallpox, diluted |
|
|
4.23.2 |
76 |
Staphylococcus bacterio lysate |
|
|
4.23.2 |
09 |
Td (adult) |
|
|
4.23.2 |
35 |
tetanus toxoid |
|
|
4.23.2 |
77 |
tick-borne encephalitis |
|
|
4.23.2 |
13 |
TIG |
|
|
4.23.2 |
95 |
TST-OT tine test |
|
|
4.23.2 |
96 |
TST-PPD intradermal |
|
|
4.23.2 |
97 |
TST-PPD tine test |
|
|
4.23.2 |
98 |
TST, NOS |
|
|
4.23.2 |
78 |
tularemia vaccine |
|
|
4.23.2 |
25 |
typhoid, oral |
|
|
4.23.2 |
41 |
typhoid, parenteral |
|
|
4.23.2 |
53 |
typhoid, parenteral, AKD (U.S. military) |
|
|
4.23.2 |
101 |
typhoid, ViCPs |
|
|
4.23.2 |
91 |
typhoid, NOS |
|
|
4.23.2 |
79 |
vaccinia immune globulin |
|
|
4.23.2 |
21 |
Varicella |
|
|
4.23.2 |
81 |
VEE, inactivated |
|
|
4.23.2 |
80 |
VEE, live |
|
|
4.23.2 |
92 |
VEE, NOS |
|
|
4.23.2 |
36 |
VZIG |
|
|
4.23.2 |
37 |
yellow fever |
|
|
4.23.2 |
998 |
no vaccine administered |
|
|
4.23.2 |
999 |
Unknown |
|
|
4.23.2 |
99 |
RESERVED - do not use |
|
|
4.23.2 |